Loomis, Sayles & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40M | Buy |
726,814
+156,057
| +27% | +$8.58M | 0.05% | 135 |
|
|
2025
Q1 | $40.3M | Buy |
570,757
+329
| +0.1% | +$23.3K | 0.06% | 131 |
|
|
2024
Q4 | $37.5M | Buy |
570,428
+240,684
| +73% | +$15.8M | 0.05% | 158 |
|
|
2024
Q3 | $23.2M | Sell |
329,744
-1,758
| -0.5% | -$124K | 0.03% | 235 |
|
|
2024
Q2 | $27.3M | Buy |
+331,502
| New | +$27.3M | 0.04% | 202 |
|
|
2023
Q4 | – | Sell |
-465
| Closed | -$41K | – | 980 |
|
|
2023
Q3 | $41K | Hold |
465
| – | – | ﹤0.01% | 634 |
|
|
2023
Q2 | $40K | Sell |
465
-121,050
| -100% | -$10.4M | ﹤0.01% | 647 |
|
|
2023
Q1 | $11.8M | Sell |
121,515
-46,607
| -28% | -$4.53M | 0.02% | 308 |
|
|
2022
Q4 | $17.4M | Sell |
168,122
-188,367
| -53% | -$19.5M | 0.03% | 247 |
|
|
2022
Q3 | $30.2M | Sell |
356,489
-25,949
| -7% | -$2.2M | 0.06% | 159 |
|
|
2022
Q2 | $31.7M | Sell |
382,438
-12,733
| -3% | -$1.06M | 0.06% | 158 |
|
|
2022
Q1 | $30.5M | Sell |
395,171
-57,743
| -13% | -$4.45M | 0.04% | 224 |
|
|
2021
Q4 | $40M | Sell |
452,914
-9,843
| -2% | -$870K | 0.05% | 203 |
|
|
2021
Q3 | $35.8M | Buy |
462,757
+2,684
| +0.6% | +$207K | 0.04% | 221 |
|
|
2021
Q2 | $38.4M | Sell |
460,073
-55,826
| -11% | -$4.66M | 0.05% | 211 |
|
|
2021
Q1 | $39M | Sell |
515,899
-3,549
| -0.7% | -$268K | 0.05% | 195 |
|
|
2020
Q4 | $45.6M | Sell |
519,448
-62,440
| -11% | -$5.48M | 0.06% | 145 |
|
|
2020
Q3 | $44.3M | Sell |
581,888
-31,175
| -5% | -$2.37M | 0.06% | 122 |
|
|
2020
Q2 | $75.6M | Sell |
613,063
-31,009
| -5% | -$3.82M | 0.12% | 73 |
|
|
2020
Q1 | $54.4M | Sell |
644,072
-53,362
| -8% | -$4.51M | 0.11% | 71 |
|
|
2019
Q4 | $59M | Sell |
697,434
-131,710
| -16% | -$11.1M | 0.1% | 78 |
|
|
2019
Q3 | $55.9M | Sell |
829,144
-23,931
| -3% | -$1.61M | 0.11% | 80 |
|
|
2019
Q2 | $73.1M | Sell |
853,075
-4,481
| -0.5% | -$384K | 0.14% | 70 |
|
|
2019
Q1 | $76.2M | Buy |
857,556
+10,355
| +1% | +$920K | 0.15% | 65 |
|
|
2018
Q4 | $72.1M | Sell |
847,201
-72,684
| -8% | -$6.19M | 0.17% | 56 |
|
|
2018
Q3 | $89.2M | Sell |
919,885
-21,407
| -2% | -$2.08M | 0.17% | 54 |
|
|
2018
Q2 | $88.7M | Buy |
941,292
+70,654
| +8% | +$6.66M | 0.18% | 53 |
|
|
2018
Q1 | $70.6M | Buy |
+870,638
| New | +$70.6M | 0.15% | 69 |
|
|
2015
Q1 | – | Sell |
-823
| Closed | -$74K | – | 725 |
|
|
2014
Q4 | $74K | Sell |
823
-105
| -11% | -$9.44K | ﹤0.01% | 687 |
|
|
2014
Q3 | $67K | Hold |
928
| – | – | ﹤0.01% | 685 |
|
|
2014
Q2 | $58K | Sell |
928
-14
| -1% | -$875 | ﹤0.01% | 708 |
|
|
2014
Q1 | $64K | Buy |
942
+708
| +303% | +$48.1K | ﹤0.01% | 695 |
|
|
2013
Q4 | $16K | Hold |
234
| – | – | ﹤0.01% | 739 |
|
|
2013
Q3 | $17K | Sell |
234
-29,295
| -99% | -$2.13M | ﹤0.01% | 716 |
|
|
2013
Q2 | $1.65K | Buy |
+29,529
| New | +$1.65K | 0.01% | 573 |
|